MELANIE OLDENDORF: Open Payments
NPI 1487827804 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 37 payments from 14 companies in 2025. Trend: 2023 $316 · 2024 $410 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $180 |
| UCB, Inc. | 6 | $142 |
| Globus Medical, Inc. | 4 | $92 |
| Medtronic, Inc. | 2 | $85 |
| Lundbeck LLC | 3 | $74 |
| Lilly USA, LLC | 3 | $57 |
| Neurelis, Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| ALON MEDICAL TECHNOLOGY | 1 | $27 |
Products named: Fintepla, QULIPTA, UBRELVY, ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY, VYEPTI, REXULTI, KISUNLA, VALTOCO.
Industry payments across LA — which companies pay providers there.
